J Stroke.  2025 May;27(2):275-278. 10.5853/jos.2024.05015.

Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial

Affiliations
  • 1Department of Neurology, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea
  • 2Department of Neurology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea
  • 3Department of Neurology, Inha University Hospital, Inha University School of Medicine, Incheon, Korea
  • 4Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea
  • 5Department of Neurology, Seoul National University Hospital, Seoul, Korea
  • 6Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea
  • 7Department of Neurology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea
  • 8Department of Neurology, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea
  • 9Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea
  • 10Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 11Department of Biostatistics, Korea University College of Medicine, Seoul, Korea

Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr